Question explored with the scientific record
Is leaky gut syndrome real?
The short version: leaky gut is a measurable biological reality, not a diagnosis you can hang a treatment protocol on with confidence.
The evidence you retrieved shows that intestinal permeability can be measured with sugar probes like lactulose and mannitol, and that it is abnormal in a long list of conditions: Crohn’s disease, liver cirrhosis, celiac disease, autism spectrum disorder, irritable bowel syndrome, psoriasis, NAFLD, and even after acute kidney injury or circadian disruption [1, 4, 10, 14, 24, 25, 23, 16]. The 2019 Gut review by Camilleri et al. calls it a real phenomenon with established measurement methods and disease associations [11]. The 2016 Current Opinion review lists over a dozen diseases linked to barrier dysfunction [26]. So the concept is real.
The problem is that the evidence does not tell you what to do about it. The best interventional study here is the 2018 glutamine trial in postinfectious IBS-D, a randomized placebo-controlled trial where 5 g of glutamine three times daily normalized permeability and cut IBS symptom scores by 40% [19]. That is a real result in a defined population. But it is one trial, and glutamine is not a cure-all. The flavonoid-rich licorice extract study in rats and the probiotic studies in mice show barrier protection in animal models [28, 17, 22]. Human data on diet, probiotics, or other interventions for leaky gut outside celiac and IBS is thin to nonexistent.
| Condition | Permeability finding | Source |
|---|---|---|
| Crohn’s disease | L:M ratio 0.076 vs 0.012 in controls | [1] |
| Liver cirrhosis | L:M ratio 0.052 vs 0.012 in controls | [1] |
| Autism spectrum disorder | 36.7% abnormal permeability vs 0% in child controls | [4] |
| IBS | Paracellular flux 107 vs 66 ng/mL in controls | [14] |
| Psoriasis | Elevated claudin-3 and I-FABP, correlated with disease severity | [24] |
| NAFLD | Increased gut permeability and LPS translocation | [25] |
My call: leaky gut is a real, measurable phenomenon with strong mechanistic plausibility and documented disease associations, but the evidence for any specific treatment outside glutamine for postinfectious IBS-D is not clear. Confidence: moderate that the phenomenon exists, low that any general intervention works.
Sources examined 30
-
Lactulose/Mannitol Test and Specificity, Sensitivity, and Area under Curve of Intestinal Permeability Parameters in Patients with Liver Cirrhosis and Crohn's Disease
This study evaluates the diagnostic value of the lactulose/mannitol test in assessing intestinal permeability in patients with liver cirrhosis and Crohn's disease, finding significant differences in permeability parameters compared to a control group.
DOI: 10.1007/s10620-007-0184-8 -
Assessment of Intestinal Permeability in Rats by Permeation of Inulin-Fluorescein
This study evaluates a novel method for assessing intestinal permeability in rat models of small intestinal injury and colitis using inulin-fluorescein, demonstrating its potential as a diagnostic tool for evaluating disease severity.
DOI: 10.1515/jbcpp.2000.11.2.143 -
An analytical method for the quantitation of mannitol and disaccharides in serum: a potentially useful technique in measuring small intestinal permeability in vivo
This study presents a novel electrochemical-HPLC method for quantifying mannitol and lactulose in serum, which simplifies the assessment of small intestinal permeability by requiring only a single blood sample instead of a lengthy urine collection.
DOI: 10.1016/s0009-8981(97)00058-2 -
Alterations of the Intestinal Barrier in Patients With Autism Spectrum Disorders and in Their First‐degree Relatives
This study noninvasively assessed intestinal permeability and bowel inflammation in 90 children with autism spectrum disorders (ASD) and 146 of their first-degree relatives, comparing them with 146 adult and 64 child controls, and found higher rates of abnormal intestinal permea…
DOI: 10.1097/mpg.0b013e3181dcc4a5 -
Permeability Profiles and Intestinal Toxicity Assessment of Hydrochlorothiazide and Its Inclusion Complex with β-Cyclodextrin Loaded into Chitosan Nanoparticles
The study develops and characterizes chitosan nanoparticles loaded with a hydrochlorothiazide:beta-cyclodextrin inclusion complex to assess intestinal permeability and toxicity using ex vivo rat gut sacs, finding that CS/HCT:βCD NPs reduce HCT-induced intestinal injury and produ…
DOI: 10.1021/acs.molpharmaceut.6b00532 -
Intestinal permeability and its relation to anthropometric and biochemical variables associated with cardiovascular risk in an elderly population
A cross-sectional study of 54 elderly adults in Brazil assessed intestinal permeability using the lactulose:mannitol test and found inverse associations with hip circumference and serum retinol, with lactulose and mannitol linking to metabolic risk markers, suggesting vitamin A …
DOI: 10.1038/s41598-025-08045-8 -
Regional Intestinal Permeability in Rats: A Comparison of Methods
This study compares the effectiveness of two preclinical models, the Ussing chamber and single-pass intestinal perfusion (SPIP), in assessing regional intestinal permeability of four model drugs in rats, revealing that SPIP is the more robust method for predicting human intestin…
DOI: 10.1021/acs.molpharmaceut.7b00279 -
Assessment of the Intestinal Barrier with Five Different Permeability Tests in Healthy C57BL/6J and BALB/cJ Mice
This study compares five different permeability tests to assess the intestinal barrier in healthy C57BL/6J and BALB/cJ mice, revealing significant sex differences in permeability and establishing normal value ranges for future research.
DOI: 10.1007/s10620-015-3935-y -
Simultaneous determination of nine model compounds in permeability samples using RP-HPLC: Application to prove the cassette administration principle in single pass intestinal perfusion study in rats
This study developed and validated a sensitive RP-HPLC method for the simultaneous determination of nine model compounds in intestinal permeability samples, demonstrating its application in validating the cassette administration principle in single-pass intestinal perfusion stud…
DOI: 10.1016/j.jpba.2012.03.048 -
Radionucleide tests for the assessment of intestinal permeability
A human study validating a short-duration radionuclide and sugar marker approach (14C-mannitol and 51Cr-EDTA) and their ratio as a practical test of intestinal permeability, capable of distinguishing untreated celiac disease from controls and monitoring treatment status.
DOI: 10.1111/j.1365-2362.1987.tb02387.x -
Leaky gut: mechanisms, measurement and clinical implications in humans
A comprehensive 2019 Gut review by Camilleri et al. synthesizes current understanding of the human intestinal barrier ('leaky gut'), detailing barrier components, methods to measure permeability, associations with various diseases and physiological states, potential dietary/gut-…
DOI: 10.1136/gutjnl-2019-318427 -
Tu1743 Consequences of in Utero and Postnatal Exposure to a Pesticide on the Intestinal Permeability in Young Rats
In a human jejunal ischemia-reperfusion model, 30 minutes of ischemia followed by 30 minutes of reperfusion increased intestinal permeability (lactulose/rhamnose ratio) and disrupted tight junctions, but both functional and morphological recovery occurred by 120 minutes of reper…
DOI: 10.1016/s0016-5085(13)63106-6 -
TOXICOKINETICS OF INDOMETHACIN-INDUCED INTESTINAL PERMEABILITY IN THE RAT
This study investigates the time course and pharmacokinetic-pharmacodynamic relationships of indomethacin-induced intestinal permeability in rats, revealing that permeability changes are dose- and time-dependent, with significant implications for understanding NSAID-induced gast…
DOI: 10.1006/phrs.1997.0194 -
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators
This study investigates the impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome (IBS) and the role of soluble mediators in this dysfunction, revealing increased paracellular permeability and decreased expression of tight junction proteins…
DOI: 10.1136/gut.2007.140806 -
Persistent epithelial dysfunction and bacterial translocation after resolution of intestinal inflammation
Resolution of intestinal inflammation in rats leads to long-lasting colonic epithelial hyporesponsiveness to secretagogues, increased colonic bacterial colonization and translocation, with inducible nitric oxide synthase contributing to translocation.
DOI: 10.1152/ajpgi.2001.281.3.g635 -
Continuous Light-Induced Circadian Rhythm Disruption Impairs Intestinal Barrier Integrity in Male C57BL/6 Mice Through Gut Microbiota Dysbiosis and the Apoptosis-Inflammation-Oxidative Stress Cascade
Continuous light–induced circadian rhythm disruption in male C57BL/6 mice impairs intestinal barrier integrity by driving gut microbiota dysbiosis and activating a cascade of apoptosis, inflammation, and oxidative stress, with implications for irritable bowel syndrome.
DOI: 10.1101/2025.11.11.687914 -
A marketed fermented dairy product containing Bifidobacterium lactis CNCM I‐2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats
This study demonstrates that a fermented dairy product containing Bifidobacterium lactis CNCM I-2494 can alleviate gut hypersensitivity and restore colonic barrier integrity in rats subjected to acute stress.
DOI: 10.1111/j.1365-2982.2011.01865.x -
Linking Psychological Stress to Epigenetic Regulation via the Gut–Liver–Brain Axis in Irritable Bowel Syndrome and Metabolic Dysfunction-Associated Fatty Liver Disease
This is a narrative review synthesizing evidence that psychological distress links irritable bowel syndrome (IBS) and metabolic dysfunction-associated fatty liver disease (MAFLD) via gut-liver-brain axis (GLBA) dysfunction and stress-induced epigenetic regulation, highlighting s…
DOI: 10.3390/livers5030043 -
Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome
In a randomized, double-blind, placebo-controlled trial, eight weeks of oral glutamine (5 g three times daily) substantially improved IBS-D symptoms and normalized intestinal permeability in adults with postinfectious IBS-D and increased permeability, vs whey protein placebo.
DOI: 10.1136/gutjnl-2017-315136 -
Novel Mast Cell Stabilizers in the Treatment of Postoperative Ileus
Preclinical evaluation of two novel mast cell stabilizers (anakinra and a Syk inhibitor, GSKcompound#1) in a mouse model of postoperative ileus shows anakinra improves intestinal transit and reduces mucosal neutrophil infiltration while GSKcompound#1 lowers neutrophil recruitmen…
DOI: 10.1016/S0016-5085(11)61506-0 -
Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice
Germ-free mice transplanted with fecal microbiota from IBS-D patients (with or without anxiety) and healthy controls show that IBS-D microbiota drives faster gut transit, impaired barrier function, increased intestinal immune activation, and anxiety-like behavior, with anxiety t…
DOI: 10.1126/scitranslmed.aaf6397 -
Gut microbiome improves postoperative cognitive function by decreasing permeability of the blood-brain barrier in aged mice
In aged mice with gut dysbiosis, anesthesia/surgery induces postoperative cognitive dysfunction associated with increased blood-brain barrier permeability and reduced tight junction proteins, which can be mitigated by oral Lactobacillus mix or sodium butyrate that enhance tight …
DOI: 10.1016/j.brainresbull.2020.08.017 -
MP257MECHANISMS OF INTESTINAL BARRIER DYSFUNCTION IN ACUTE KIDNEY INJURY
This study investigates the mechanisms of intestinal barrier dysfunction in acute kidney injury (AKI), revealing that AKI significantly increases intestinal permeability through the loosening of tight junctions and alters gut environmental factors, which may contribute to immune…
DOI: 10.1093/ndt/gfx166.mp257 -
Role of damage to intestinal barrier in development of psoriasis
Systematic overview of evidence linking intestinal barrier dysfunction and gut permeability to psoriasis, highlighting elevated claudin-3 and I-FABP, zonulin, and calprotectin in patients and suggesting gut-targeted therapies may modulate disease activity.
DOI: 10.33667/2078-5631-2021-35-34-37 -
Role of Gut Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease
Gut barrier dysfunction across four barriers is closely related to NAFLD pathogenesis, with permeability, LPS translocation, TLR signaling, and IgA involvement, and with bile acids, glutamine, and probiotics as potential modulators.
DOI: 10.1155/2015/287348 -
Leaky gut – concept or clinical entity?
A comprehensive review of the gut barrier, its components and permeability measurement techniques, the evidence for barrier dysfunction across GI diseases, and the view that barrier dysfunction is context-dependent with potential therapeutic implications but not a settled univer…
DOI: 10.1097/mog.0000000000000243 -
MICU1 may be a promising intervention target for gut-derived sepsis induced by intra-abdominal hypertension
In a rat model of intra-abdominal hypertension (IAH), MICU1 expression is upregulated while MCU is downregulated at the transcriptional level; in cultured human Caco-2 cells, MICU1 knockdown disrupts epithelial barrier function, increases oxidative stress and apoptosis, and redu…
DOI: 10.1038/cddiscovery.2016.80 -
A flavonoid rich standardized extract of Glycyrrhiza glabra protects intestinal epithelial barrier function and regulates the tight-junction proteins expression
flavonoid-rich Glycyrrhiza glabra extract GutGard preserves intestinal barrier integrity by maintaining tight junction proteins and reducing inflammatory mediators in TNF-α–stimulated Caco-2 cells and TNBS-induced colitis in rats.
DOI: 10.1186/s12906-021-03500-1 -
Omega-3 polyunsaturated fatty acids and the inflammatory state of the Caco-2 gut epithelium model
The study uses the Caco-2 gut epithelium model to test whether DHA and EPA (omega-3 polyunsaturated fatty acids) modulate inflammatory responses and barrier function in the presence of inflammatory stimuli and PT-gliadin, finding that DHA/EPA do not alter paracellular permeabili…
DOI: 10.1017/s0029665120000890 -
Glutamine Enhances Tight Junction Protein Expression and Modulates Corticotropin-Releasing Factor Signaling in the Jejunum of Weanling Piglets ,
In weanling piglets, dietary 1% L-glutamine mitigates weaning-induced intestinal barrier dysfunction by preserving jejunal tight junction proteins (occludin, claudin-1, ZO-2, ZO-3), reducing mucosal corticotropin-releasing factor (CRF) signaling, and improving villus height and …
DOI: 10.3945/jn.114.202515